FTSE announces confirmed changes to its quarterly review, including potential additions such as Groww and Meesho, and a planned exit for Biocon, with the index adjustment scheduled for Sept. 18, 2026. The revised constituents take effect from Sept. 21, 2026, according to the timing outlined in the announcement.
The reports frame the reshuffle as a key market event because index changes can influence fund flows and trading activity around the inclusion and exit dates. While the outlets list a set of 10 stocks expected to attract inflows on likely inclusion and identify Biocon as the stock to exit, they do not provide additional debate over the rationale for each change in the materials provided. Overall, the emphasis is on the confirmed timetable and the specific names involved, rather than broader macro or company-specific developments.
Across the sources, the core points converge on the FTSE review being confirmed, the effective date of Sept. 21, 2026, and the implementation date of Sept. 18, 2026, with Groww and Meesho highlighted among stocks expected to see demand.
